PARK7 and melanoma: In this study, we asked whether doxorubicin and other selected chemotherapeutic drugs used in melanoma (such as temozolomide) and its analog dacarbazine: (i) have the ability to stably bind α‐syn and DJ‐1 (alone or as complex) and (ii) whether this binding induces destabilization and further in vitro degradation.